Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H1107

Introduced
2/27/25  

Caption

Prohibiting discrimination against 340b drug discount program participants

Impact

If enacted, H1107 is expected to enhance access to medications for low-income patients by ensuring that the entities responsible for dispensing discounted drugs are not financially penalized compared to other pharmacies. This is particularly vital in a healthcare landscape where affordability of medications plays a significant role in patient adherence to treatment regimens. The bill reinforces the importance of the 340B program in maintaining healthcare services for populations that rely on these discounted medications, particularly those served by community health centers.

Summary

House Bill 1107, introduced by Representative Daniel Cahill, seeks to prohibit discrimination against participants in the 340B drug discount program in Massachusetts. This bill aims to amend existing laws to ensure that both 340B-covered entities—typically hospitals and health centers serving vulnerable patient populations—and their contract pharmacies are reimbursed fairly by insurance plans for covered outpatient drugs. The legislation clarifies that these covered entities should not face lower reimbursement rates or more stringent requirements than similarly situated pharmacies not participating in the 340B program, thereby promoting equitable treatment in the distribution of drug pricing.

Contention

Some stakeholders may express concerns regarding the potential for increased costs to insurance providers if they are required to comply with the reimbursement stipulations laid out in H1107. Opponents may argue that the bill imposes undue regulatory burdens on insurers and could lead to higher insurance premiums for the general population. Moreover, the need for compliance with new requirements could complicate existing relationships between insurers and pharmacies, raising questions about the administrative feasibility of the proposed changes.

Companion Bills

MA H4490

Replaced by Prohibiting discrimination against 340b drug discount program participants

Previously Filed As

MA H4490

Prohibiting discrimination against 340b drug discount program participants

MA S819

Prohibiting discrimination against 340b drug discount program participants

MA H1274

Prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program

MA H4494

Prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program

MA HB1755

Relative to the 340B discounted drug purchasing program.

MA H1527

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

MA SB2751

340B drug discount program entities; remove distributor from prohibition of certain discriminating actions related to.

MA LD1018

An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program

MA S1638

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

MA H1281

Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs

Similar Bills

TX HB3317

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

TX SB1236

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

HI SB2208

Relating To Pharmacy Benefit Managers.

HI SB2047

Relating To Pharmacy Benefit Managers.

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.